Valery Yu Alakhov

This inventor holds 23 USPTO granted patents, plus 2 CIPO patents and 7 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Supratek Pharma Inc., Everon Biosciences, Inc., Softkemo Pharma Corp.. Active years: 1997-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Valery Yu Alakhov. Retrieved from https://idiyas.com/inventor/valery-yu-alakhov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23

% Patents Active = 60.9

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 7 (Patent Applications = 3)

Average Co-Inventor Count = 3.3

ph-index = 8

Forward Citations = 404(Granted Patents)

Location History:

Ouebec, CA (1998)
Baie d′Urfe, CA (2001)
Montreal, CA (2003)
Baie d'Urfe, CA (1997 - 2012)
Quebec, CA (1998 - 2014)
Ile Bizard, CA (2013 - 2018)

Company Filing History:

Everon Biosciences, Inc.

patents

1 out of 2

Softkemo Pharma Corp.

patents

4. 1 out of 969

The Board of Regents of the University of Nebraska

patents

5. 1 out of 834,570

Other

patents

Years Active: 1997-2018

Loading Chart...

Areas of Expertise:

Cabazitaxel

Rapamycin

Bendamustine

Doxorubicin

Protein Production

Dendritic Cells

Vascular Endothelial Growth Factor

Copolymer Compositions

Biological Agents

Chemotherapy

Autoimmune Diseases

Viral Infections

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9919053 - Cabazitaxel composition (2018-03-20),

2. 8912215 - Rapamycin composition (2014-12-16),

3. 8703964 - Bendamustine cyclopolysaccharide compositions (2014-04-22),

4. 8436032 - Bendamustine cyclopolysaccharide compositions (2013-05-07),

5. 8389558 - Bendamustine amphiphilic anionic compositions (2013-03-05),

6. 8383663 - Bendamustine anionic-catioinic cyclopolysaccharide compositions (2013-02-26),

7. 8148338 - Doxorubicin formulations for anti-cancer use (2012-04-03),

8. 7772255 - Method of treating tumors with azaxanthones (2010-08-10),

9. 7422875 - Compositions and methods for increasing protein production (2008-09-09),

10. 7256180 - Compositions and methods for inducing activation of dendritic cells (2007-08-14),

11. 7112654 - Ligand for vascular endothelial growth factor receptor (2006-09-26),

12. 6733755 - Ligand for vascular endothelial growth factor receptor (2004-05-11),

13. 6696274 - Ligand for enhancing oral and CNS delivery of biological agents (2004-02-24),

14. 6656459 - Compositions of non-ionic block copolymers to treat autoimmune and inflammatory diseases, and to reduce graft/implantation, and methods of use thereof (2003-12-02),

15. 6387406 - Copolymer compositions for oral delivery (2002-05-14),

Title: Valery Yu Alakhov - Pioneering Inventor from Quebec, CA

Introduction: Valery Yu Alakhov is a trailblazing inventor hailing from Quebec, CA, known for her innovative contributions to various fields.

Latest Patents: Valery Yu Alakhov holds several patents in the areas of sustainable energy solutions, advanced materials, and medical devices, showcasing her diverse range of expertise.

Career Highlights: With a background in engineering and a passion for problem-solving, Valery Yu Alakhov has had a successful career marked by groundbreaking inventions that have had a significant impact on industries worldwide.

Collaborations: Throughout her career, Valery Yu Alakhov has collaborated with leading research institutions, universities, and companies to further develop and commercialize her inventions, solidifying her reputation as a visionary inventor.

Conclusion: Valery Yu Alakhov's relentless pursuit of innovation and her dedication to creating solutions for the future make her a standout figure in the world of inventors, inspiring the next generation of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.